| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | REYNOLDS AMERICAN INC | 4,688,458 | 323,082,000 | 45.87% | ||
| 2 | ALKERMES PLC SHS | 2,799,690 | 170,697,000 | 24.24% | ||
| 3 | PROTHENA CORP PLC | 3,708,171 | 141,430,000 | 20.08% | ||
| 4 | NORTHWEST BIOTHERAPEUTICS INC | 9,379,987 | 69,131,000 | 9.82% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001213900-15-006766, filed 2015.09.04).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
